LINKED CONTENT This article is linked to Chaudhary et al and & Stanley papers. To view these articles, visit https://doi.org/10.1111/apt.16170 https://doi.org/10.1111/apt.16368

BACKGROUND Gastrointestinal (GI) bleeding is a leading cause of death in dengue. This study aims to identify predictors for GI bleeding in adult dengue patients, emphasizing the impact of existing comorbid disease(s). METHODS Of 1300 adults with dengue virus infection, 175 (mean age, 56.5±13.7 years) patients with GI bleeding and 1,125 (mean age, 49.2±15.6 years) without GI bleeding (controls...

BACKGROUND Acid-suppressive medications are increasingly prescribed for noncritically ill hospitalized patients, although the incidence of nosocomial gastrointestinal (GI) tract bleeding (GI bleeding) and magnitude of potential benefit from this practice are unknown. We aimed to define the incidence of nosocomial GI bleeding outside of the intensive care unit and examine the association between...

BACKGROUND Bleeding is a major complication of warfarin therapy. Assessing the cost of warfarin-associated bleeding may more fully describe the costs associated with warfarin use. OBJECTIVE To assess health care costs related to warfarin-associated bleeding in patients with newly diagnosed atrial fibrillation (AF). METHODS Medical and pharmacy claims were analyzed for patients with AF (ICD-...

upper gastrointestinal bleeding (ugib) is defi ned as bleeding that results from lesions located above the ligament of treitz and is a common cause for emergency hospital admissions in patients with gastrointestinal disorders. ugib also increases the risk of morbidity and mortality in patients already hospitalized for other reasons. according to epidemiological surveys of acute ugib in iran, pe...

A 64-year-old male with a remote history of upper gastrointestinal (GI) bleeding secondary to peptic ulcer disease presented to the emergency department aft er having hematochezia. He denied having abdominal pain, hematemesis, rectal tenderness, or prior hemorrhoids. Upon arrival to the emergency department, the patient had a syncopal event while having another episode of hematochezia. Th e pat...

INTRODUCTION The study goal was to evaluate the cost-effectiveness of drug-eluting stent (DES) placement with consideration of gastrointestinal (GI) bleeding risk. DES reduce the need for future coronary revascularization, but require prolonged dual anti-platelet (DAT) therapy, which may increase the risk for GI bleeding. While DES have been found to be cost-effective in patients at average ris...

AIMS The risk of gastrointestinal (GI) bleeding limits the use of antiplatelet and anticoagulant drugs. Risk factors for GI bleeding in post- myocardial infarction (MI) patients have not been well defined. We sought to identify risk factors for GI bleeding in patients following MI. METHODS AND RESULTS The VALsartan In Acute myocardial iNfarcTion trial (VALIANT) enrolled 14 703 post-MI patient...